Factors associated with poor outcomes among hospitalized patients with COVID-19: Experience from a MERS-CoV referral hospital.
COVID-19
ICU
Invasive mechanical ventilation
Risk factors
Journal
Journal of infection and public health
ISSN: 1876-035X
Titre abrégé: J Infect Public Health
Pays: England
ID NLM: 101487384
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
received:
27
05
2021
revised:
27
09
2021
accepted:
29
09
2021
pubmed:
10
10
2021
medline:
11
11
2021
entrez:
9
10
2021
Statut:
ppublish
Résumé
Coronavirus disease 2019 (COVID-19) has resulted in millions of deaths, including more than 6000 deaths in the Kingdom of Saudi Arabia (KSA). Identifying key predictors of intensive care unit (ICU) admission and mortality among infected cases would help in identifying individuals at risk to optimize their care. We aimed to determine factors of poor outcomes in hospitalized patients with COVID-19 in a large academic hospital in Riyadh, KSA that serves as a Middle East Respiratory Syndrome coronavirus (MERS-CoV) referral center. This is a single-center retrospective cohort study of hospitalized patients between March 15 and August 31, 2020. The study was conducted at King Saud University Medical City (KSUMC). COVID-19 infection was confirmed using real-time reverse transcriptase polymerase chain reaction (RT-PCR) for SARS-COV-2. Demographic data, clinical characteristics, laboratory, radiological features, and length of hospital stay were obtained. Poor outcomes were, admission to ICU, need for invasive mechanical ventilation (IMV), and in-hospital all-cause mortality. Out of 16,947 individuals tested in KSUMC, 3480 (20.5%) tested positive for SARS-CoV-2 and of those 743 patients (21%) were hospitalized. There were 62% males, 77% were younger than 65 years. Of all cases, 204 patients (28%) required ICU admission, 104 (14%) required IMV, and 117 (16%) died in hospital. In bivariate analysis, multiple factors were associated with mortality among COVID-19 patients. Further multivariate analysis revealed the following factors were associated with mortality: respiratory rate more than 24/min and systolic blood pressure <90 mmHg in the first 24h of presentation, lymphocyte count <1 × 10 Variable factors were identified as predictors of different outcomes among COVID-19 patients. The only predictor of IMV was a low initial Ct values of SARS-CoV-2 PCR. The presence of tachypnea, hypotension, lymphopenia, and elevated AST in the first 48h of presentation were independently associated with mortality. This study provides possible independent predictors of mortality and invasive mechanical ventilation. The data may be helpful in the early identification of high-risk COVID-19 patients in areas endemic with MERS-CoV.
Sections du résumé
BACKGROUND
BACKGROUND
Coronavirus disease 2019 (COVID-19) has resulted in millions of deaths, including more than 6000 deaths in the Kingdom of Saudi Arabia (KSA). Identifying key predictors of intensive care unit (ICU) admission and mortality among infected cases would help in identifying individuals at risk to optimize their care. We aimed to determine factors of poor outcomes in hospitalized patients with COVID-19 in a large academic hospital in Riyadh, KSA that serves as a Middle East Respiratory Syndrome coronavirus (MERS-CoV) referral center.
METHODS
METHODS
This is a single-center retrospective cohort study of hospitalized patients between March 15 and August 31, 2020. The study was conducted at King Saud University Medical City (KSUMC). COVID-19 infection was confirmed using real-time reverse transcriptase polymerase chain reaction (RT-PCR) for SARS-COV-2. Demographic data, clinical characteristics, laboratory, radiological features, and length of hospital stay were obtained. Poor outcomes were, admission to ICU, need for invasive mechanical ventilation (IMV), and in-hospital all-cause mortality.
RESULTS
RESULTS
Out of 16,947 individuals tested in KSUMC, 3480 (20.5%) tested positive for SARS-CoV-2 and of those 743 patients (21%) were hospitalized. There were 62% males, 77% were younger than 65 years. Of all cases, 204 patients (28%) required ICU admission, 104 (14%) required IMV, and 117 (16%) died in hospital. In bivariate analysis, multiple factors were associated with mortality among COVID-19 patients. Further multivariate analysis revealed the following factors were associated with mortality: respiratory rate more than 24/min and systolic blood pressure <90 mmHg in the first 24h of presentation, lymphocyte count <1 × 10
CONCLUSION
CONCLUSIONS
Variable factors were identified as predictors of different outcomes among COVID-19 patients. The only predictor of IMV was a low initial Ct values of SARS-CoV-2 PCR. The presence of tachypnea, hypotension, lymphopenia, and elevated AST in the first 48h of presentation were independently associated with mortality. This study provides possible independent predictors of mortality and invasive mechanical ventilation. The data may be helpful in the early identification of high-risk COVID-19 patients in areas endemic with MERS-CoV.
Identifiants
pubmed: 34627061
pii: S1876-0341(21)00314-2
doi: 10.1016/j.jiph.2021.09.023
pmc: PMC8485705
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1658-1665Informations de copyright
Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Références
Biosci Rep. 2020 Dec 23;40(12):
pubmed: 33201172
J Multidiscip Healthc. 2021 Apr 15;14:839-852
pubmed: 33883900
East Mediterr Health J. 2020 Jan 30;26(1):39-46
pubmed: 32043544
Saudi Med J. 2009 Jul;30(7):876-81
pubmed: 19617999
J Infect Public Health. 2021 Aug;14(8):994-1000
pubmed: 34153731
PLoS One. 2021 Jan 7;16(1):e0244532
pubmed: 33411707
Blood Rev. 2021 Jul;48:100785
pubmed: 33309392
Healthcare (Basel). 2021 Jan 28;9(2):
pubmed: 33525596
Eur Rev Med Pharmacol Sci. 2020 Dec;24(24):13065-13071
pubmed: 33378060
BMC Infect Dis. 2021 Jan 9;21(1):39
pubmed: 33421989
Diagnosis (Berl). 2020 May 26;7(2):91-96
pubmed: 32352401
N Engl J Med. 2020 Jun 25;382(26):2534-2543
pubmed: 32459916
J Gen Intern Med. 2020 May;35(5):1545-1549
pubmed: 32133578
EClinicalMedicine. 2020 Jul 04;24:100448
pubmed: 32766546
JAMA Netw Open. 2020 Jun 1;3(6):e2012270
pubmed: 32543702
NCHS Data Brief. 2020 Feb;(360):1-8
pubmed: 32487284
Saudi Med J. 2020 Nov;41(11):1217-1226
pubmed: 33130842
PLoS One. 2020 Nov 3;15(11):e0241742
pubmed: 33141836
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
J Med Virol. 2020 Oct;92(10):1875-1883
pubmed: 32441789
Eur J Clin Invest. 2020 Oct;50(10):e13362
pubmed: 32726868
Infect Control Hosp Epidemiol. 2021 Jun;42(6):772-775
pubmed: 33323138
Travel Med Infect Dis. 2020 May - Jun;35:101608
pubmed: 32114075
BMC Infect Dis. 2021 Jan 25;21(1):113
pubmed: 33494706
J Med Virol. 2021 Feb;93(2):1188-1193
pubmed: 32975814
J Epidemiol Glob Health. 2021 Mar;11(1):98-104
pubmed: 33095982
Scand J Trauma Resusc Emerg Med. 2020 Oct 27;28(1):106
pubmed: 33109234
Saudi Med J. 2020 Oct;41(10):1090-1097
pubmed: 33026050
BMJ Open. 2020 Nov 10;10(11):e042398
pubmed: 33172949
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Biomed Res Int. 2019 Mar 05;2019:8073057
pubmed: 30949511
Travel Med Infect Dis. 2020 Sep - Oct;37:101807
pubmed: 32599173
J Intern Med. 2020 Sep;288(3):335-344
pubmed: 32352202
J Infect Public Health. 2021 Jan;14(1):6-11
pubmed: 33341486
BMJ. 2020 May 29;369:m1996
pubmed: 32471884
Circ Res. 2020 Jun 5;126(12):1671-1681
pubmed: 32302265
J Infect Public Health. 2021 Jun;14(6):759-765
pubmed: 34022734
Nicotine Tob Res. 2020 Aug 24;22(9):1653-1656
pubmed: 32399563
BMJ. 2020 May 22;369:m1985
pubmed: 32444460